Aqr Capital Management LLC Vista Gen Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.09 - $4.8 $935 - $49,881	10,392 New	10,392 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $17,476 - $34,357	-19,860 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $87,471 - $160,363	-76,729 Reduced 79.44%	19,860 $25,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $141,701 - $234,188	-84,851 Reduced 46.77%	96,589 $188,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $187,950 - $247,492	71,737 Added 65.39%	181,440 $497,000
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $215,017 - $345,564	109,703 New	109,703 $346,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.